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Chromosomal translocations that juxtapose antigen receptor genes and oncogenes are frequently 
associated with lymphoid malignancies. In this issue, Robbiani et al. (2008) show that activation-
induced deaminase (AID), an enzyme involved in antigen receptor gene diversification, generates 
DNA double-strand breaks (DSBs) in oncogenes, and Tsai et al. (2008) propose that AID and the 
recombinase-activating gene (RAG) endonuclease may collaborate to generate off-target DSBs.DNA double-stranded breaks (DSBs) are generated by geno-
toxic agents and by cellular endonucleases as intermedi-
ates in several important physiologic processes including 
V(D)J recombination, class switch recombination of the immu-
noglobulin (Ig) heavy (H) chain gene, DNA replication, gene 
transcription, and meiosis. Highly conserved DNA repair path-
ways generally rejoin the two broken DNA ends at a single DSB, 
preserving the integrity of the genome. During V(D)J recombi-
nation and Ig class switch recombination, broken DNA ends 
from two distinct DSBs are joined to form new gene products 
that are essential for normal immune responses. On occasion, 
these DNA ends can be aberrantly joined to those generated 
by DSBs elsewhere in the genome, leading to the formation of 
lesions that are potentially oncogenic, such as chromosomal 
translocations, deletions, or inversions. Two papers in this 
issue of Cell demonstrate that the enzymes required for intro-
ducing DNA DSBs at antigen receptor loci during diversifica-
tion processes can also generate off-target DSBs required for 
the formation of chromosomal translocations (Robbiani et al., 
2008; Tsai et al., 2008). Here, we discuss the different mecha-
nisms by which the off-target effects of these enzymes could 
participate in the formation of potentially oncogenic chromo-
somal translocations.
The Diversification of Antigen Receptor Genes
In both developing and mature lymphocytes, antigen recep-
tor genes undergo diversification processes that involve DNA 
DSB intermediates. The second exon of all antigen receptor 
genes, which encodes the variable region of antigen receptor 
chains, is assembled in developing B and T lymphocytes from 
component variable (V), joining (J) and in some cases diversity 
(D) gene segments through the process of V(D)J recombina-
tion. This process is initiated by the recombinase-activating 
gene (RAG) -1 and -2 proteins, which together form the RAG 
endonuclease (Fugmann et al., 2000). RAG introduces DSBs 
at the border of the two recombining gene segments and their 
flanking RAG recognition sites, termed recombination signals. 
Recombination signals are composed of conserved heptamer 
and nonamer sequences flanking nonconserved 12- or 23-base 
pair spacers. DNA cleavage at two gene segments is coupled and occurs only after RAG, and a pair of recombination signals 
with dissimilar length spacers form a synaptic complex. The 
resulting pairs of signal ends and coding ends are processed 
and joined by the nonhomologous end-joining pathway (NHEJ) 
of DSB repair to form a relatively precise signal joint and an 
imprecise coding joint, respectively (Bassing et al., 2002). The 
coding joint remains in the chromosome and participates in 
the formation of the second exon of antigen receptor genes, 
whereas the signal joint can either remain in the chromosome, 
during rearrangements that occur by inversion, or be excised 
from the chromosome as an extrachromosomal circle, during 
rearrangements that occur by deletion.
In mature activated B cells, genes encoding IgH chains are fur-
ther diversified through class switch recombination. This process 
is required to generate the antibodies of differing isotypes that 
participate in the diverse effector phases of the humoral immune 
response (Chaudhuri et al., 2007). Class switch recombination 
is initiated through the introduction of DNA DSBs in specialized 
repetitive switch region sequences that lie upstream of the exons 
encoding the different constant regions in the IgH locus. Gen-
eration of these DSBs is dependent on the activation induced 
cytidine deaminase (AID), an enzyme that deaminates cytosine 
residues on the single-stranded DNA templates exposed during 
switch region transcription. The resulting U:G mismatch is con-
verted into a single-strand nick by pathways that rely on uracil 
DNA glycosylase or mismatch repair; these single strand nicks 
are converted into DSBs, possibly through the introduction of a 
closely staggered single-strand nick on the opposite DNA strand. 
DSBs generated in this manner at two distinct switch regions 
are joined, appending the variable region exons to new constant 
region exons and excising the intervening DNA as an extrachro-
mosomal circle. Unlike V(D)J recombination, in which the gen-
eration of RAG DSBs at the two recombining gene segments is 
mechanistically coupled, the formation of AID-mediated DSBs 
at distinct switch regions is likely to occur independently, though 
mechanisms that juxtapose the switch regions prior to cleavage 
may exist (Wuerffel et al., 2007; Zarrin et al., 2007).
Activated B cells also undergo Ig gene diversification 
through the process of somatic hypermutation, which cre-
ates point mutations in variable region exons of the IgH and Ig Cell 135, December 12, 2008 ©2008 Elsevier Inc. 1009
light (L) chain genes (Di Noia and Neuberger, 2007). Somatic 
hypermutation, like class switch recombination, requires AID 
to generate an initial U:G mismatch, which is then repaired 
through different pathways that result in point mutations at the 
deaminated cytidine and in the immediately flanking regions 
(Di Noia and Neuberger, 2007). It is not clear whether somatic 
hypermutation proceeds through an obligate DSB intermedi-
ate; however, the notion that this process can, on occasion, 
result in the formation of DSBs is supported by the presence 
of AID-dependent translocations involving variable region 
exons of the IgH locus that are already completely assembled 
(Dorsett et al., 2007).
Oncogenic Translocations in Lymphocytes
Many lymphoid malignancies have signature chromosomal 
translocations that are likely critical for transformation. A sub-
set of these translocations arise from the misjoining of DSBs 
generated during antigen receptor diversification processes 
to breaks located near an oncogene (Figure 1) (Kuppers and 
Dalla-Favera, 2001). Breakpoints are often clustered in specific 
regions near these oncogenes, likely due to selection for the 
transforming ability of the resulting translocations. However, 
these regions could also have features that make them prone 
to DSB generation, for example, due to DNA damage-inducing 
agents, during DNA replication or transcription, or due to the 
formation of non-B-DNA structures. Alternatively, DSBs at 
these regions might be generated by “off-target” activities of 
RAG and AID in lymphocytes that are actively diversifying their 
antigen receptor genes.
Off-Target RAG Activity
Truncated versions of the RAG proteins are capable of inte-
grating signal end flanked DNA fragments into plasmid sub-
strates in vitro through a transposition-type reaction (Fugmann 
Figure 1. Off-Target Activity of AID and RAG
(A) RAG-mediated DNA double-strand breaks 
(DSBs) are generated at the border of gene seg-
ments (blue rectangles) and recombination signals 
(blue triangles) at lymphocyte antigen receptor 
loci. RAG can also generated DSBs at cryptic 
recombination signals (green triangle) and non-B 
DNA structures at non-antigen receptor loci (off-
target gene, green rectangle). The joining of RAG-
generated broken DNA ends at antigen receptor 
loci to those generated at off-target genes could 
result in the generation of a chromosomal translo-
cation. RAG could also catalyze the insertion of a 
segment of DNA flanked by recombination signals 
into an off-target gene by RAG-mediated transpo-
sition.
(B) AID-mediated DSBs are generated in switch 
regions (S) that lie between the variable region ex-
ons (V) and the constant region exons (C) during 
class switch recombination and possibly also, on 
occasion, in variable region exons during somatic 
hypermutation. AID-mediated DSBs may also oc-
cur at different off-target genes in the genome, 
and the joining of these broken DNA ends to those 
generated by AID at antigen receptor loci could 
result in the formation of chromosomal transloca-
tions.
(C) In cells that express both RAG and AID, AID 
could modify sequences near off-target genes that 
could make these sequences susceptible to cleav-
age by RAG. Broken DNA ends generated in this 
fashion could then be joined to those generated 
at antigen receptor loci by RAG or by AID during 
class switch recombination (shown) or somatic hy-
permutation (not shown) resulting in the formation 
of translocations.
(D and E) In cells that express both RAG and AID, 
translocations could also be generated by joining 
broken DNA ends generated by AID at antigen 
receptor loci to those generated by RAG at off-
target genes (D), or broken DNA ends generated 
by RAG at antigen receptor loci could be joined to 
those generated by AID at off-target genes. Final-
ly, it should be noted that off target DNA breaks, 
generated by RAG or AID, could be joined to each 
other or to DNA breaks generated in other ways, 
forming translocations that do not involve antigen 
receptor loci.1010 Cell 135, December 12, 2008 ©2008 Elsevier Inc.
et al., 2000). If this occurred in vivo in developing lymphocytes, 
it would have potentially dangerous consequences, given that 
signal end flanked DNA fragments generated during deletional 
rearrangements could be randomly inserted into the genome, 
where they may disrupt local gene expression. Moreover, the 
transposition of signal ends generated during inversional rear-
rangements could generate reciprocal chromosomal translo-
cations, and transposition of a single signal end could lead to 
unbalanced chromosomal translocations and other types of 
chromosomal aberrations.
Experimental approaches that permit the selection of 
cells in which DNA fragments flanked by signal ends have 
integrated ectopically into the genome suggest that RAG-
mediated transposition can occur in vivo (Messier et al., 
2003; Reddy et al., 2006). Using a sensitive PCR approach, 
Curry et al. (2007) found that a signal end flanked DNA frag-
ment generated during rearrangement of the T cell receptor 
β locus can be integrated into the genome in primary T cells. 
However, none of the isolated integrants had target site 
nucleotide duplications indicative of transposition. Together, 
these studies suggest that chromosomal aberrations gener-
ated by RAG-mediated transposition of signal ends liber-
ated during V(D)J recombination occur at very low levels. In 
this regard, although truncated RAG proteins can catalyze 
transposition in vivo, full-length RAG proteins do so much 
less efficiently, if at all, suggesting that the regions absent 
in the truncated RAG proteins have evolved to regulate RAG 
activity and limit this potentially dangerous reaction (Seki-
guchi et al., 2001).
Another mechanism by which RAG could generate chro-
mosomal translocations is through the misjoining of two DNA 
ends generated by RAG: one at a recombination signal in an 
antigen receptor locus, and one at a cryptic recombination 
signal in a non-antigen receptor gene. DNA cleavage at these 
sites by RAG could arise through formation of an interchro-
mosomal synaptic complex, though these RAG breaks could 
also be generated independently. Finally, sequences that lack 
a canonical recombination signal may possess other features 
that make them suitable substrates for RAG-mediated cleav-
age (Raghavan and Lieber, 2006).
Off-Target AID Activity
AID is expressed in activated B cells, and its deamination 
activity is targeted primarily to switch regions for class switch 
recombination and variable regions for somatic hypermutation 
(Chaudhuri et al., 2007). Spontaneous tumors that develop in 
transgenic mice overexpressing the cytokine interleukin 6 (IL-6) 
contain translocations between the IgH locus and the c-myc 
oncogene resembling those found in sporadic Burkitt’s lym-
phoma (Dorsett et al., 2007; Ramiro et al., 2004). AID is required 
for the formation of these translocations due almost certainly 
to its role in generating DSBs at the IgH locus. Although the 
basis for DSB generation at the c-myc locus is not known, AID 
can, at a very low level, introduce point mutations at many non-
antigen receptor genes in activated B cells, raising the pos-
sibility that off-target AID activity may generate the DSBs that 
participate in c-myc/IgH translocations (Kuppers and Dalla-
Favera, 2001; Liu et al., 2008).In this issue of Cell, Robbiani et al. (2008) address whether 
AID activity is required to generate both the IgH and c-myc 
DSBs that are necessary for the formation of c-myc/IgH chro-
mosomal translocations. To do this, they developed an elegant 
experimental approach whereby the I-SceI endonuclease can 
be used to introduce DSBs in c-myc and immediately upstream 
of the IgH switch µ region (Sµ). As observed previously, c-myc/
IgH translocations are found in activated B cells that express 
AID but not in those that are AID deficient. However, in acti-
vated AID-deficient B cells, the introduction of I-SceI DSBs at 
both IgH and c-myc leads to the robust formation of c-myc/
IgH translocations. Importantly, these translocations are not 
observed in AID-deficient B cells where I-SceI DSBs are gen-
erated at either IgH or c-myc alone. Together, these findings 
demonstrate that the c-myc/IgH translocations that form in 
activated B cells require the generation of AID-dependent IgH 
and c-myc DSBs.
53BP1 foci, indicative of possible DSB generation, were 
undetectable at the c-myc locus in wild-type activated B 
cells but were present in cells that overexpressed AID and 
in those with I-SceI-induced DSBs at c-myc (Robbiani et 
al., 2008). Moreover, the generation of I-SceI breaks at the 
c-myc locus increased the frequency of c-myc/IgH trans-
locations involving AID-induced DSBs at the IgH locus. 
The introduction of I-SceI DSBs at IgH, on the other hand, 
did not increase the frequency of translocations with AID-
induced c-myc DSBs. Together, these findings suggest that 
AID-induced DSBs at the c-myc locus are generated less 
efficiently, or perhaps repaired more rapidly, than those at 
IgH. Although the mechanisms that target AID to c-myc have 
not been fully elucidated, Robbiani et al. show that, like the 
IgH locus, AID activity at c-myc is dependent on a functional 
c-myc promoter.
Combining Off-Target Activities of AID and RAG
Also, in this issue of Cell, Tsai et al. (2008) theorize that 
off-target recognition sites for RAG cleavage may be gen-
erated through sequence modifications introduced by 
AID. The foundation of this study is an extensive analysis 
of 1700 breakpoints at chromosomal translocations com-
monly occurring in human lymphoid tumors. Translocation 
breakpoints in some of these tumors were enriched in CpG 
dinucleotides. The cytosine of the CpG dinucleotide is a tar-
get for methylation, and deamination of a methylated cyto-
sine would result in conversion of cytosine to thymine. The 
resulting T:G mismatch is more stable than a U:G mismatch, 
generated by deamination of a nonmethylated cytosine. Tsai 
et al. show that these T:G mismatches can generate a DNA 
structure that is recognized by RAG, resulting in the intro-
duction of a single-strand nick in vitro.
From these findings, it is proposed that AID may modify 
methylated CpG sequences, permitting the formation of T:G 
mismatches that, in turn, form substrates for RAG-mediated 
cleavage. A major tenet of this proposal is that B cells can 
express both RAG and AID simultaneously. In this regard, 
Tsai et al. note that translocations involving CpG clusters 
are markedly enriched in human lymphoid malignancies that 
appear phenotypically to be derived from pro-B/pre-B cells. Cell 135, December 12, 2008 ©2008 Elsevier Inc. 1011
From this, they speculate that AID and RAG may both be 
expressed in some developing human B cells and can func-
tion together in these cases to generate off-target DSBs that 
participate in translocations. Although this notion is consis-
tent with the expression of AID in developing B cells from 
a quasimonoclonal mouse (as a consequence of restricted 
heavy and light chain usage), mice with a sensitive AID 
expression reporter failed to reveal any AID expression in 
developing B cells (Crouch et al., 2007; Mao et al., 2004). 
Notably, transitional B cells newly released from the bone 
marrow may retain RAG protein expression in the periphery 
and, upon activation, could conceivably express both AID 
and RAG (Bassing et al., 2002). Consistent with this notion, 
Wang et al. (2008) observed that XRCC4-deficient B cells 
develop chromosomal translocations that involve the join-
ing of DSBs in the IgLλ locus, likely generated by RAG, to 
DSBs in the IgH locus, likely generated by AID. They con-
clude that such lesions could be formed in transitional B 
cells that coexpress RAG and AID. Finally, if RAG can be re-
expressed in some activated mature B cells, this could also 
lead to simultaneous expression of AID and RAG by these 
cells (Bassing et al., 2002).
Perspective
In lymphoid malignancies, certain chromosomal translocations 
involving antigen receptor loci and various oncogenes dis-
play breakpoint features suggestive of the joining of two DNA 
breaks both generated by enzymatic processes involved in nor-
mal antigen receptor gene diversification. That this is the case, 
at least for the c-myc/IgH translocations seen in some B cell 
malignancies, is now made clear by the studies of Robbiani et 
al. It remains to be determined to what extent off-target DSBs 
generated by AID, RAG, or a combination of AID and RAG, as 
suggested by Tsai et al., are required for other translocations 
found in lymphoid tumors. Furthermore, it is possible that trans-
locations that do not involve antigen receptor genes could result 
from the joining of two off-target breaks generated by RAG, AID, 
or possibly a combination of RAG and AID in cells that express 
both of these proteins. Finally, although the off-target activity of 
RAG and/or AID may generate DSBs at ectopic regions of the 
genome, whether or not these lesions are ultimately resolved as 
translocations or other chromosomal aberrations will likely be 
influenced by many additional factors.1012 Cell 135, December 12, 2008 ©2008 Elsevier Inc.ReFeRenCes
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